WVE Wave Life Sciences Ltd. - Ordinary Shares
$5.16
가격 · 8월 18, 2026
기준 재무 정보 7월 30, 2026
52주 범위
$5–$21
1% of range
애널리스트 평점
BUY
20 analysts
목표 주가
$19
+269% upside
P/E (TTM)
-14.0
ROE
—
순이익률
—
Wave Life Sciences Ltd. - Ordinary Shares 정보 위키백과 회사 개요
WVE 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$5.16
시가총액
—
P/E (TTM)
-14.0
EPS (TTM)
$-1.21
매출 (TTM)
$43M
배당 수익률
—
ROE
—
부채/자본
—
52주 범위
$5 – $21
WVE 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
Configure
10년 성과 매출, 순이익, 마진 및 EPS 추세
매출 및 순이익
$43M
2016-12-31
→
2025-12-31
EPS
$-1.21
2021-12-31
→
2025-12-31
잉여현금흐름
—
마진
—
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
지표
5년 추세
WVE
동종업계 중앙값
P/E (TTM)
-14.0
19.5
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
지표
5년 추세
WVE
동종업계 중앙값
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
지표
5년 추세
WVE
동종업계 중앙값
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
지표
5년 추세
WVE
동종업계 중앙값
Revenue YoY (매출 YoY)
-60.6%
—
Revenue CAGR 3Y (매출 CAGR 3년)
127.1%
—
Revenue CAGR 5Y (매출 CAGR 5년)
16.3%
—
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
지표
5년 추세
WVE
동종업계 중앙값
WVE 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
매수
20 명의 애널리스트
- 적극 매수 6 30.0%
- 매수 13 65.0%
- 보유 1 5.0%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
16 명의 애널리스트 · 2026-08-17
중앙값
$15.00
평균
$19.06
← 모든 목표가 하회
$5.16
저가
$12.00
고가
$42.00
중앙값 목표
$15.00
+190.7%
평균 목표
$19.06
+269.4%
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
평균 서프라이즈
0.01%
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 6월 30일 | $-0.34 | $-0.31 | -0.03% |
| 2026년 3월 31일 | $-0.13 | $-0.33 | 0.20% |
| 2025년 12월 31일 | $-0.30 | $-0.27 | -0.03% |
| 2025년 9월 30일 | $-0.32 | $-0.30 | -0.02% |
| 2025년 6월 30일 | $-0.31 | $-0.29 | -0.02% |
| 2025년 3월 31일 | $-0.29 | $-0.26 | -0.03% |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 13
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $43M | $108M | $113M | $4M | $41M | $20M | $16M | $14M | $4M | $1M | $152.0K | |
| R&D Expense | $183M | $160M | $130M | $116M | $122M | $131M | $175M | $134M | $79M | $41M | $9M | |
| SG&A Expense | $75M | $59M | $51M | $51M | $46M | $43M | $49M | $40M | $27M | $16M | $10M | |
| Operating Expenses | $258M | $219M | $181M | $166M | $168M | $173M | $224M | $174M | $106M | $57M | $19M | |
| Operating Income | $-215M | $-110M | $-68M | $-163M | $-127M | $-153M | $-208M | $-160M | $-102M | $-56M | $-19M | |
| Other Non-op | $527.0K | $3M | $2M | $7.0K | $5M | $2M | $10M | $10M | $-331.0K | $-50.0K | $56.0K | |
| Pretax Income | $-204M | $-97M | $-58M | $-161M | $-122M | $-151M | $-194M | $-147M | $-101M | $-55M | $-19M | |
| Income Tax | $0 | $0 | $-677.0K | $681.0K | $-204.0K | $-841.0K | $0 | $69.0K | $842.0K | $482.0K | $44.0K | |
| Net Income | $-204M | $-97M | $-58M | $-162M | $-122M | $-150M | $-194M | $-147M | $-102M | $-56M | $-19M | |
| EPS (Basic) | $-1.21 | $-0.70 | $-0.54 | $-2.05 | $-2.36 | · | · | · | · | · | · | |
| EPS (Diluted) | $-1.21 | $-0.70 | $-0.54 | $-2.05 | $-2.36 | · | · | · | · | · | · | |
| Shares (Basic) | 168,649,795 | 138,277,468 | 106,097,268 | 78,855,810 | 51,825,566 | · | · | · | · | · | · | |
| Shares (Diluted) | 168,649,795 | 138,277,468 | 106,097,268 | 78,855,810 | 51,825,566 | · | · | · | · | · | · |
대차대조표 23
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $602M | $302M | $200M | $88M | $151M | $184M | $147M | $175M | $143M | $150M | $161M | |
| Receivables | $1M | $1M | $21M | · | · | $30M | $20M | $10M | $1M | · | · | |
| Prepaid Expense | $8M | $10M | $10M | $8M | $7M | $10M | $10M | $7M | $7M | $1M | $146.0K | |
| Other Current Assets | $3M | $7M | $4M | $2M | $5M | $5M | $9M | $11M | · | · | · | |
| Current Assets | $615M | $320M | $235M | $99M | $163M | $230M | $185M | $202M | $150M | $152M | $161M | |
| PP&E (Net) | $7M | $10M | $13M | $17M | $22M | $29M | $36M | $40M | $27M | $9M | $3M | |
| PP&E (Gross) | $57M | $56M | $56M | $55M | $54M | $54M | $53M | $49M | $32M | $11M | $4M | |
| Accum. Depreciation | $50M | $46M | $43M | $38M | $32M | $25M | $17M | $10M | $4M | $2M | $2M | |
| Other Non-current Assets | $16.0K | $55.0K | $156.0K | · | · | · | · | · | · | · | · | |
| Total Assets | $638M | $352M | $275M | $146M | $207M | $279M | $284M | $296M | $182M | $165M | $165M | |
| Accounts Payable | $16M | $16M | $13M | $17M | $7M | $14M | $9M | $13M | $8M | $5M | $3M | |
| Accrued Liabilities | $7M | $5M | $2M | $4M | $4M | $2M | $5M | $6M | $3M | · | · | |
| Current Liabilities | $95M | $111M | $186M | $72M | $64M | $121M | $118M | $130M | $18M | $12M | $4M | |
| Capital Leases | $9M | $18M | $25M | $32M | $25M | $26M | $29M | · | · | $16.0K | $78.0K | |
| Other Non-current Liabilities | · | · | · | $190.0K | · | $474.0K | $2M | $2M | $2M | $796.0K | $163.0K | |
| Total Liabilities | $112M | $135M | $227M | $184M | $167M | $189M | $213M | $215M | $34M | $22M | $4M | |
| Common Stock | $1.62B | $1.18B | $935M | $803M | $750M | $694M | $540M | $375M | $310M | $216M | $185M | |
| Paid-in Capital | $228M | $156M | $129M | $119M | $88M | $72M | $57M | $38M | $22M | $10M | $3M | |
| Retained Earnings | $-1.33B | $-1.12B | $-1.02B | $-967M | $-806M | $-683M | $-533M | $-340M | $-193M | $-90M | $-35M | |
| AOCI | $-250.0K | $-262.0K | $-124.0K | $-29.0K | $181.0K | $389.0K | $267.0K | $153.0K | $116.0K | $-291.0K | $41.0K | |
| Stockholders' Equity | $518M | $210M | $40M | $-45M | $32M | $83M | $64M | $73M | $140M | $135M | $153M | |
| Liabilities + Equity | $638M | $352M | $275M | $146M | $207M | $279M | $284M | $296M | $182M | $165M | $165M | |
| Shares Outstanding | 187,660,263 | 153,037,286 | 119,162,234 | 86,924,643 | 59,841,116 | 48,778,678 | 34,340,690 | 29,472,197 | 27,829,079 | 23,502,169 | 21,551,423 |
현금 흐름 10
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | $2M | $784.0K | $594.0K | |
| Stock-based Comp | · | · | · | · | · | · | · | · | · | · | $4M | |
| Deferred Tax | $0 | $0 | $0 | · | · | · | · | · | $908.0K | $-698.0K | $36.0K | |
| Operating Cash Flow | $-187M | $-151M | $-19M | $-128M | $-89M | $-116M | $-188M | $-23M | $-84M | $-32M | $-13M | |
| CapEx | $718.0K | $938.0K | $1M | $1M | $560.0K | $1M | $4M | $10M | $19M | $6M | $2M | |
| Investing Cash Flow | $-718.0K | $-938.0K | $-1M | $-1M | $-560.0K | $-1M | $-4M | $-10M | $-19M | $-6M | · | |
| Stock Issued | · | · | $94M | $51M | · | $94M | $162M | $60M | $94M | $30M | $12M | |
| Financing Cash Flow | $488M | $254M | $133M | $67M | $56M | $155M | $164M | $65M | $94M | $29M | · | |
| Net Change in Cash | $300M | $102M | $112M | $-62M | $-34M | $37M | $-28M | $32M | $-8M | $-8M | $160M | |
| Taxes Paid | · | · | · | · | · | · | · | · | $-11.0K | $554.0K | · |
성장률 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -60.6% | -4.4% | 3005.1% | -91.1% | 104.0% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 127.1% | 38.3% | 78.0% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 16.3% | · | · | · | · | · | · | · | · | · | · |
가치 평가 (TTM) 5
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $43M | $108M | $113M | $4M | $41M | $20M | $16M | $14M | $4M | $1M | $152.0K | |
| Net Income TTM | $-204M | $-97M | $-58M | $-162M | $-122M | $-150M | $-194M | $-147M | $-102M | $-56M | $-19M | |
| P/E | -14.0 | -17.7 | -9.4 | -3.4 | -1.3 | · | · | · | · | · | · | |
| P / Tangible Book | 6.2 | 9.0 | 15.2 | · | 5.8 | 4.6 | · | · | · | · | · | |
| Earnings Yield | -7.1% | -5.7% | -10.7% | -29.3% | -75.2% | · | · | · | · | · | · |
손익계산서 15
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $38M | · | · | $9M | $9M | · | · | $20M | $13M | $49M | $22M | $13M | $285.0K | $375.0K | $2M | |
| R&D Expense | $51M | $47M | $53M | $46M | $43M | $41M | $45M | $41M | $40M | $33M | $32M | $33M | $31M | $28M | $30M | $27M | |
| SG&A Expense | $25M | $22M | $21M | $18M | $18M | $18M | $16M | $15M | $14M | $14M | $13M | $12M | $12M | $12M | $13M | $12M | |
| Operating Expenses | $76M | $70M | $74M | $64M | $61M | $59M | $61M | $56M | $55M | $47M | $45M | $46M | $43M | $39M | $43M | $40M | |
| Operating Income | $-74M | $-31M | $-56M | $-56M | $-53M | $-50M | $23M | $-64M | $-35M | $-34M | $4M | $-23M | $-30M | $-39M | $-42M | $-38M | |
| Interest Income | $5M | $5M | · | $2M | $2M | $3M | · | $2M | $2M | $3M | · | · | · | · | · | · | |
| Other Non-op | $-275.0K | $-80.0K | $234.0K | $324.0K | $-82.0K | $51.0K | $3M | $337.0K | $-18.0K | $365.0K | $171.0K | $118.0K | $1M | $-701.0K | $744.0K | $254.0K | |
| Pretax Income | $-69M | $-26M | $-53M | $-54M | $-50M | $-47M | $29M | $-62M | $-33M | $-32M | $7M | $-21M | $-27M | $-39M | $-41M | $-38M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-677.0K | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-69M | $-26M | $-53M | $-54M | $-50M | $-47M | $29M | $-62M | $-33M | $-32M | $7M | $-21M | $-27M | $-39M | $-41M | $-38M | |
| EPS (Basic) | $-0.34 | $-0.13 | $-0.29 | $-0.32 | $-0.31 | $-0.29 | $0.26 | $-0.47 | $-0.25 | $-0.24 | $0.07 | $-0.20 | $-0.27 | $-0.42 | $-0.62 | $-0.62 | |
| EPS (Diluted) | $-0.34 | $-0.13 | $-0.29 | $-0.32 | $-0.31 | $-0.29 | $0.26 | $-0.47 | $-0.25 | $-0.24 | $0.07 | $-0.20 | $-0.27 | $-0.42 | $-0.62 | $-0.62 | |
| Shares (Basic) | 204,008,712 | 200,167,869 | -325,604,079 | 167,739,208 | 163,987,640 | 162,572,026 | -253,084,680 | 132,563,467 | 129,527,003 | 129,271,678 | 106,025,063 | 105,462,414 | 102,056,712 | 93,900,484 | 66,479,293 | 60,516,616 | |
| Shares (Diluted) | 204,008,712 | 200,167,869 | -325,604,079 | 167,739,208 | 163,987,640 | 162,572,026 | -253,084,680 | 132,563,467 | 129,527,003 | 129,271,678 | 106,975,231 | 105,462,414 | 102,056,712 | 93,900,484 | 66,479,293 | 60,516,616 | |
| EBITDA | $-74M | $-31M | · | $-56M | $-53M | $-50M | · | $-64M | $-35M | $-34M | $4M | $-23M | $-30M | $-39M | $-42M | $-38M |
대차대조표 24
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $368M | $545M | $602M | $196M | $208M | $243M | $302M | $311M | $154M | $181M | $140M | $173M | $208M | $97M | $123M | $62M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | $25M | $25M | $50M | |
| Receivables | $888.0K | $0 | $1M | $10M | $2M | · | $1M | $0 | $1M | $0 | $7M | · | · | · | · | · | |
| Prepaid Expense | $12M | $13M | $8M | $7M | $7M | $8M | $10M | $11M | $12M | $11M | $8M | $9M | $9M | $7M | $5M | $7M | |
| Other Current Assets | $4M | $3M | $3M | $3M | $7M | $7M | $7M | $3M | $5M | $5M | $4M | $3M | $3M | $2M | $7M | $6M | |
| Current Assets | $508M | $561M | $615M | $215M | $224M | $258M | $320M | $325M | $172M | $197M | $159M | $185M | $220M | $131M | $160M | $124M | |
| PP&E (Net) | $7M | $7M | $7M | $8M | $9M | $10M | $10M | $11M | $12M | $12M | $14M | $15M | $16M | $19M | $20M | $21M | |
| PP&E (Gross) | · | · | $57M | · | · | · | $56M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $51M | $50M | $50M | $49M | $48M | $47M | $46M | $45M | $44M | $44M | $42M | $40M | $39M | · | · | · | |
| Other Non-current Assets | $667.0K | $386.0K | $16.0K | $22.0K | $728.0K | $448.0K | $55.0K | · | · | · | · | · | · | · | · | · | |
| Total Assets | $558M | $584M | $638M | $241M | $252M | $288M | $352M | $359M | $209M | $235M | $200M | $230M | $267M | $182M | $213M | $167M | |
| Accounts Payable | $20M | $19M | $16M | $14M | $15M | $14M | $16M | $13M | $18M | $12M | $13M | $12M | $12M | $16M | $11M | $10M | |
| Accrued Liabilities | $5M | $5M | $7M | $5M | $3M | $2M | $5M | $3M | $2M | $2M | $3M | $3M | $2M | $2M | $3M | $3M | |
| Current Liabilities | $51M | $50M | $95M | $86M | $87M | $87M | $111M | $171M | $173M | $166M | $100M | $140M | $133M | $64M | $64M | $58M | |
| Capital Leases | $40M | $7M | $9M | $11M | $14M | $16M | $18M | $20M | $22M | $24M | $27M | $29M | $31M | $34M | $35M | $24M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | $190.0K | $190.0K | · | · | $868.0K | |
| Total Liabilities | $105M | $72M | $112M | $109M | $105M | $109M | $135M | $209M | $204M | $202M | $233M | $274M | $294M | $178M | $174M | $160M | |
| Common Stock | $1.63B | $1.63B | $1.62B | $1.22B | $1.19B | $1.18B | $1.18B | $1.14B | $951M | $950M | $841M | $840M | $838M | $803M | $802M | $751M | |
| Paid-in Capital | $248M | $237M | $228M | $174M | $168M | $161M | $156M | $153M | $136M | $132M | $127M | $125M | $122M | $117M | $113M | $92M | |
| Retained Earnings | $-1.42B | $-1.35B | $-1.33B | $-1.27B | $-1.22B | $-1.17B | $-1.12B | $-1.15B | $-1.09B | $-1.06B | $-1.01B | $-1.02B | $-995M | $-924M | $-885M | $-843M | |
| AOCI | $-172.0K | $-254.0K | $-250.0K | $-190.0K | $-161.0K | $-204.0K | $-262.0K | $-159.0K | $-279.0K | $-198.0K | $-182.0K | $-150.0K | $-50.0K | $-123.0K | $-47.0K | $95.0K | |
| Stockholders' Equity | $454M | $512M | $518M | $125M | $139M | $172M | $210M | $142M | $-3M | $25M | $-40M | $-52M | $-35M | $-5M | $31M | $-53.0K | |
| Liabilities + Equity | $558M | $584M | $638M | $241M | $252M | $288M | $352M | $359M | $209M | $235M | $200M | $230M | $267M | $182M | $213M | $167M | |
| Shares Outstanding | 193,277,622 | 192,337,566 | 187,660,263 | 160,288,481 | 155,673,292 | 154,093,313 | 153,037,286 | 148,392,939 | 122,479,289 | 122,321,384 | 99,011,901 | 98,566,816 | 98,104,844 | 86,841,523 | 86,724,658 | 60,859,968 |
현금 흐름 8
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-54M | $-60M | $-34M | $-45M | $-46M | $-63M | $-44M | $-46M | $-27M | $-33M | $-34M | $-37M | $86M | $-26M | $-29M | $-40M | |
| CapEx | $884.0K | $438.0K | $-1.0K | $248.0K | $306.0K | $165.0K | $86.0K | $383.0K | $52.0K | $417.0K | $198.0K | $72.0K | $489.0K | $457.0K | $492.0K | $208.0K | |
| Investing Cash Flow | $-123M | $-438.0K | $1.0K | $-248.0K | $-306.0K | $-165.0K | $-86.0K | $-383.0K | $-52.0K | $-417.0K | $-198.0K | $-72.0K | $-489.0K | $-501.0K | $25M | $-50M | |
| Stock Issued | · | · | · | · | · | · | · | $174M | $0 | $14M | $-35M | $-35M | $0 | $-229.0K | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $14M | · | · | $35M | · | · | · | |
| Financing Cash Flow | $330.0K | $3M | $440M | $33M | $12M | $4M | $35M | $204M | $653.0K | $15M | $2M | $2M | $35M | $17.0K | $66M | $1M | |
| Net Change in Cash | $-177M | $-57M | $406M | $-12M | $-35M | $-59M | $-9M | $157M | $-27M | $-19M | $-33M | $-36M | $120M | $-26M | $61M | $-89M | |
| Free Cash Flow | · | $-60M | · | · | · | $-63M | · | · | · | $-34M | · | · | $85M | · | · | $-40M |
수익성 7
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -3248.3% | -81.8% | · | · | -606.5% | -542.8% | · | · | -177.7% | -274.8% | 9.0% | -106.2% | -234.2% | -13648.8% | -11243.7% | -2176.8% | |
| Net Margin | -3052.6% | -68.2% | · | · | -580.2% | -510.9% | · | · | -167.2% | -251.7% | 14.7% | -95.5% | -212.0% | -13685.6% | -11012.3% | -2160.8% | |
| Pretax Margin | -3052.6% | -68.2% | · | · | -580.2% | -510.9% | · | · | -167.2% | -251.7% | 13.4% | -95.5% | -212.0% | -13685.6% | -11012.3% | -2160.8% | |
| EBITDA Margin | -3248.3% | -81.8% | · | · | -606.5% | -542.8% | · | · | -177.7% | -274.8% | 9.0% | -106.2% | -234.2% | -13648.8% | -11243.7% | -2176.8% | |
| ROA | -17.1% | -6.0% | · | -17.9% | -21.9% | -17.9% | · | -22.1% | -15.0% | -12.6% | 3.8% | -9.5% | -12.6% | -20.4% | -19.7% | -18.4% | |
| ROE | -23.4% | -7.6% | · | -40.5% | -74.3% | -47.5% | · | -122.2% | 119.3% | 676.9% | -32.2% | 203.2% | 157.7% | -307.3% | -156.5% | -143.3% | |
| ROIC | -16.3% | -6.1% | · | -45.2% | -37.9% | -29.0% | · | -45.1% | 1006.5% | -135.7% | -12.1% | 45.4% | 87.2% | 860.8% | -136.2% | 71875.5% |
유동성 및 지급능력 2
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.0 | 11.3 | · | 2.5 | 2.6 | 3.0 | · | 1.9 | 1.0 | 1.2 | 1.6 | 1.3 | 1.7 | 2.0 | 2.5 | 2.1 | |
| Quick Ratio | 7.3 | 10.9 | · | 2.4 | 2.4 | 2.8 | · | 1.8 | 0.9 | 1.1 | 1.5 | 1.2 | 1.6 | 1.9 | 2.3 | 1.9 |
효율성 2
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | · | · | 0.0 | 0.0 | · | · | 0.1 | 0.0 | 0.3 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | 1.8 | · | · | · | 6.0 | · | · | · | 30.5 | 0.8 | 3.3 | · | · | · | · | · |
가치 평가 (TTM) 10
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | $104M | $104M | $97M | $85M | $36M | $15M | $39M | $41M | · | |
| Net Income TTM | $-200M | $-177M | · | $-213M | $-192M | $-173M | · | $-119M | $-78M | $-73M | $-80M | $-129M | $-146M | $-124M | $-124M | $-125M | |
| Market Cap | $1.12B | $1.39B | · | $1.17B | $1.01B | $1.25B | · | $1.22B | $611M | $755M | $569M | $359M | $425M | $313M | $282M | $122M | |
| P/E | -5.3 | -6.9 | · | -5.3 | -4.9 | -6.5 | · | -9.2 | -8.0 | -9.6 | -7.0 | -2.4 | -2.2 | -2.0 | -1.5 | · | |
| P/S | · | · | · | · | · | · | · | 11.8 | 5.9 | 7.8 | 6.7 | 10.1 | 27.7 | 8.1 | 6.8 | · | |
| P/B | 2.5 | 2.7 | · | 9.4 | 7.3 | 7.2 | · | 8.6 | -175.8 | 29.7 | -14.1 | -6.9 | -12.2 | -69.4 | 9.1 | -2296.6 | |
| P / Tangible Book | 2.5 | 2.7 | · | 9.4 | 7.3 | 7.2 | · | 8.6 | · | 29.7 | · | · | · | · | 9.1 | · | |
| P / Cash Flow | · | -23.4 | · | · | · | -19.8 | · | · | · | -22.6 | · | · | 5.0 | · | · | -3.1 | |
| P / FCF | · | -23.2 | · | · | · | -19.7 | · | · | · | -22.3 | · | · | 5.0 | · | · | -3.0 | |
| Earnings Yield | -18.9% | -14.5% | · | -19.0% | -20.3% | -15.5% | · | -10.8% | -12.4% | -10.4% | -14.3% | -41.5% | -44.6% | -49.3% | -65.8% | · |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 매출 | $43M | $108M | $113M | $4M | $41M |
| 순이익 | $-204M | $-97M | $-58M | $-162M | $-122M |
| 희석 EPS | $-1.21 | $-0.70 | $-0.54 | $-2.05 | $-2.36 |
최신 뉴스 이 회사 관련 최근 헤드라인
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
📊
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 264개의 제출자 · $892.5M 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
기관 활동 — Q2 2026 대 이전 분기
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 56 (+5 이전 분기 대비) | 37 (+1 이전 분기 대비) | 93 (-18 이전 분기 대비) | 59 (+4 이전 분기 대비) | +16.8M |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $156,727,684 | 26,975,505 | 17.56% | 주식 |
| GSK plc | $106,007,465 | 18,245,691 | 11.88% | 주식 |
| MAVERICK CAPITAL LTD | $59,715,848 | 10,278,115 | 6.69% | 주식 |
| Driehaus Capital Management LLC | $31,624,661 | 5,443,143 | 3.54% | 주식 |
| PRIMECAP MANAGEMENT CO/CA/ | $31,110,354 | 5,354,622 | 3.49% | 주식 |
| 683 Capital Management, LLC | $28,759,500 | 4,950,000 | 3.22% | 주식 |
| STATE STREET CORP | $28,116,432 | 4,839,317 | 3.15% | 주식 |
| READYSTATE ASSET MANAGEMENT LP | $27,464,678 | 4,727,139 | 3.08% | 주식 |
| M28 Capital Management LP | $26,657,930 | 4,588,284 | 2.99% | 주식 |
| TWO SIGMA INVESTMENTS, LP | $21,541,656 | 3,707,686 | 2.41% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $19,277,729 | 3,317,246 | 2.16% | 주식 |
| FMR LLC | $17,099,004 | 2,943,030 | 1.92% | 주식 |
| ALGERT GLOBAL LLC | $16,370,343 | 2,817,615 | 1.83% | 주식 |
| Qube Research & Technologies Ltd | $16,128,560 | 2,776,000 | 1.81% | 주식 |
| Squarepoint Ops LLC | $14,765,778 | 2,541,442 | 1.65% | 주식 |
| VANGUARD GROUP INC | $14,386,233 | 846,249 | 1.61% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $12,263,463 | 2,110,751 | 1.37% | 주식 |
| MORGAN STANLEY | $12,000,799 | 2,065,542 | 1.34% | 주식 |
| Pfizer Inc | $10,931,250 | 1,875,000 | 1.22% | 주식 |
| MILLENNIUM MANAGEMENT LLC | $10,523,548 | 1,811,282 | 1.18% | 주식 |
| D. E. Shaw & Co., Inc. | $10,296,645 | 1,772,228 | 1.15% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $10,175,651 | 1,751,403 | 1.14% | 주식 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $9,920,932 | 1,746,643 | 1.11% | 주식 |
| RENAISSANCE TECHNOLOGIES LLC | $9,903,261 | 1,704,520 | 1.11% | 주식 |
| DIMENSIONAL FUND ADVISORS LP | $9,201,210 | 1,583,685 | 1.03% | 주식 |
| GOLDMAN SACHS GROUP INC | $8,877,262 | 1,527,928 | 0.99% | 주식 |
| Point72 Asset Management, L.P. | $8,627,786 | 1,484,989 | 0.97% | 주식 |
| RTW INVESTMENTS, LP | $7,843,500 | 1,350,000 | 0.88% | 주식 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $7,114,025 | 1,224,445 | 0.80% | 주식 |
| EMERALD ADVISERS, LLC | $7,111,237 | 1,223,965 | 0.80% | 주식 |
| BlackRock, Inc. | $5,539,777 | 953,490 | 0.62% | 주식 |
| SymBiosis Capital Partners, LLC | $5,437,500 | 750,000 | 0.61% | 주식 |
| Pictet Asset Management Holding SA | $5,330,146 | 917,409 | 0.60% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $5,157,403 | 887,677 | 0.58% | 주식 |
| Aberdeen Group plc | $5,092,221 | 876,458 | 0.57% | 주식 |
| EMERALD MUTUAL FUND ADVISERS TRUST | $4,926,874 | 847,999 | 0.55% | 주식 |
| BAKER BROS. ADVISORS LP | $4,779,527 | 822,638 | 0.54% | 주식 |
| BNP PARIBAS FINANCIAL MARKETS | $4,712,241 | 811,057 | 0.53% | 주식 |
| CAPITAL FUND MANAGEMENT S.A. | $4,268,874 | 734,746 | 0.48% | 주식 |
| SPHERA FUNDS MANAGEMENT LTD. | $3,708,360 | 638,272 | 0.42% | 주식 |
| Y-Intercept (Hong Kong) Ltd | $3,544,646 | 610,094 | 0.40% | 주식 |
| Susquehanna Portfolio Strategies, LLC | $3,533,607 | 608,194 | 0.40% | 주식 |
| TANG CAPITAL MANAGEMENT LLC | $3,486,000 | 600,000 | 0.39% | 주식 |
| Walleye Capital LLC | $3,401,482 | 585,453 | 0.38% | 주식 |
| CITADEL ADVISORS LLC | $2,789,695 | 480,154 | 0.31% | 주식 |
| BANK OF AMERICA CORP /DE/ | $2,569,042 | 442,176 | 0.29% | 주식 |
| XTX Topco Ltd | $2,556,011 | 439,933 | 0.29% | 주식 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $2,375,674 | 408,894 | 0.27% | 주식 |
| Connor, Clark & Lunn Investment Management Ltd. | $2,319,398 | 399,208 | 0.26% | 주식 |
| Trexquant Investment LP | $2,208,782 | 380,169 | 0.25% | 주식 |
| HSBC HOLDINGS PLC | $2,172,683 | 370,449 | 0.24% | 주식 |
| Woodline Partners LP | $2,036,585 | 350,531 | 0.23% | 주식 |
| Ishara Investments LP | $1,905,680 | 328,000 | 0.21% | 주식 |
| BARCLAYS PLC | $1,766,839 | 304,103 | 0.20% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,739,514 | 299,400 | 0.19% | 주식 |
| PLATINUM INVESTMENT MANAGEMENT LTD | $1,599,313 | 275,269 | 0.18% | 주식 |
| JPMORGAN CHASE & CO | $1,543,989 | 265,614 | 0.17% | 주식 |
| Swiss National Bank | $1,514,086 | 260,600 | 0.17% | 주식 |
| ExodusPoint Capital Management, LP | $1,458,728 | 251,072 | 0.16% | 주식 |
| Privium Fund Management B.V. | $1,400,268 | 241,010 | 0.16% | 주식 |
| F/m Investments LLC | $1,365,844 | 235,085 | 0.15% | 주식 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1,339,112 | 230,484 | 0.15% | 주식 |
| Newtyn Management, LLC | $1,249,150 | 215,000 | 0.14% | 주식 |
| TD Asset Management Inc | $1,127,291 | 194,026 | 0.13% | 주식 |
| ALPS ADVISORS INC | $1,125,780 | 193,766 | 0.13% | 주식 |
| RHUMBLINE ADVISERS | $1,125,195 | 193,667 | 0.13% | 주식 |
| Sofinnova Investments, Inc. | $1,099,560 | 189,253 | 0.12% | 주식 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1,052,744 | 145,206 | 0.12% | 주식 |
| Elmind Capital, LP | $1,033,285 | 177,846 | 0.12% | 주식 |
| ADAR1 Capital Management, LLC | $929,600 | 160,000 | 0.10% | 주식 |
| Bank of New York Mellon Corp | $911,560 | 156,895 | 0.10% | 주식 |
| ALLIANCEBERNSTEIN L.P. | $904,293 | 124,730 | 0.10% | 주식 |
| Burkehill Global Management, LP | $871,500 | 150,000 | 0.10% | 주식 |
| BOOTHBAY FUND MANAGEMENT, LLC | $842,450 | 145,000 | 0.09% | 주식 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $836,692 | 144,009 | 0.09% | 주식 |
| STATE OF WISCONSIN INVESTMENT BOARD | $830,981 | 143,026 | 0.09% | 주식 |
| WELLINGTON MANAGEMENT GROUP LLP | $801,995 | 138,037 | 0.09% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $775,635 | 133,500 | 0.09% | 콜 옵션 |
| CITIGROUP INC | $680,287 | 117,089 | 0.08% | 주식 |
| WELLS FARGO & COMPANY/MN | $675,395 | 116,247 | 0.08% | 주식 |
| James J. Burns & Company, LLC | $666,988 | 114,800 | 0.07% | 주식 |
| IEQ CAPITAL, LLC | $618,451 | 106,446 | 0.07% | 주식 |
| Cetera Investment Advisers | $609,341 | 104,878 | 0.07% | 주식 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $608,336 | 104,705 | 0.07% | 주식 |
| VANGUARD ASSET MANAGEMENT, Ltd | $604,211 | 103,995 | 0.07% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $593,782 | 102,200 | 0.07% | 풋 옵션 |
| Mariner, LLC | $593,759 | 102,195 | 0.07% | 주식 |
| Bridgefront Capital, LLC | $589,448 | 101,454 | 0.07% | 주식 |
| UBS Group AG | $531,034 | 91,400 | 0.06% | 콜 옵션 |
| MetLife Investment Management, LLC | $513,587 | 88,397 | 0.06% | 주식 |
| Ikarian Capital, LLC | $495,507 | 85,285 | 0.06% | 주식 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $476,000 | 81,955 | 0.05% | 주식 |
| Entropy Technologies, LP | $467,409 | 80,449 | 0.05% | 주식 |
| EXCHANGE TRADED CONCEPTS, LLC | $467,310 | 80,432 | 0.05% | 주식 |
| Quadrature Capital Ltd | $459,368 | 79,065 | 0.05% | 주식 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | $451,007 | 77,626 | 0.05% | 주식 |
| a16z Perennial Management, L.P. | $450,966 | 77,619 | 0.05% | 주식 |
| MARSHALL WACE, LLP | $443,645 | 76,359 | 0.05% | 주식 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $432,450 | 74,432 | 0.05% | 주식 |
| FEDERATED HERMES, INC. | $408,304 | 70,276 | 0.05% | 주식 |
회사 내부자 21 명의 내부자 · 8 임원 · 9 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Paul Bolno | President and CEO | 2026년 2월 5일 A | 275,520 | 0 | 2 | $-2,336,201 |
| Kyle Moran | Chief Financial Officer | 2026년 2월 5일 A | 134,385 | 0 | 7 | $-4,151,988 |
| David G Gaiero | Interim CFO | 2020년 3월 3일 A | 6,392 | 0 | 0 | $0 |
| Keith Regnante | Chief Financial Officer | 2019년 3월 7일 A | 29,186 | 0 | 0 | $0 |
| Chris Francis | SVP, Corporate Development, Head of Emerging Areas | 2026년 2월 26일 M | 61,867 | 0 | 14 | $-7,103,233 |
| Chandra Vargeese | Chief Technology Officer, Head of Platform Discovery Sciences | 2026년 2월 5일 A | 408,246 | 0 | 1 | $-43,417 |
| Michael A. Panzara | Chief Medical Officer, Head of Therapeutics Discovery and Development | 2022년 7월 25일 A | 109,103 | 0 | 0 | $0 |
| Mark Baldry | Chief Commerical Officer | 2019년 8월 5일 A | 39,000 | 0 | 0 | $0 |
| Gregory L. Verdine | 이사 | 2025년 12월 8일 S | 275,217 | 0 | 3 | $-369,461 |
| Christian O Henry | 이사 | 2025년 12월 8일 M | 12,700 | 0 | 4 | $-1,369,324 |
| Mark Corrigan | 이사 | 2025년 12월 8일 S | 28,815 | 0 | 2 | $-217,265 |
| Amy Pott | 이사 | 2020년 8월 18일 A | — | 0 | 0 | $0 |
| Peter Kolchinsky | 이사 | 2020년 8월 18일 A | — | 0 | 0 | $0 |
| Koji Miura | 이사 | 2019년 8월 15일 A | — | 0 | 0 | $0 |
| Masaharu Tanaka | 이사 | 2016년 11월 10일 A | — | 0 | 0 | $0 |
| Takeshi Wada | 이사 | 2016년 11월 10일 A | — | 0 | 0 | $0 |
| Adrian Rawcliffe | — | 2026년 8월 12일 S | 0 | 0 | 3 | $-806,604 |
| Tan Aik Na | — | 2026년 8월 11일 S | 24,968 | 0 | 10 | $-2,020,004 |
| Ken Takanashi | — | 2026년 8월 11일 S | 20,079 | 0 | 1 | $-23,223 |
| Heidi L Wagner | — | 2026년 8월 11일 M | 44,930 | 0 | 3 | $-231,070 |
| Roberto Guerciolini | — | 2016년 12월 7일 M | 4,000 | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
행동주의자 및 5% 이상 소유자 4 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×9 제출 서류 | 2026년 8월 11일 | 16.80% | 수정본 | — | SEC |
| Shin Nippon Biomedical Laboratories, Ltd., SNBL USA, Ltd., Ken Takanashi ×6 제출 서류 | 2022년 8월 12일 | — | 최초 제출 | — | SEC |
| Kagoshima Shinsangyo Sousei Investment Limited Partnership, Kagoshima Development Co. Ltd. ×5 제출 서류 | 2022년 7월 20일 | — | 최초 제출 | — | SEC |
| RA Capital Management, LLC, Peter Kolchinsky ×3 제출 서류 | 2019년 1월 28일 | — | 최초 제출 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 28 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| GNOM · Global X Funds | 1.03% | 87,259 NS | 2026년 5월 31일 | N-PORT |
| PILL · Direxion Shares ETF Trust | 0.67% | 12,254 NS | 2026년 4월 30일 | N-PORT |
| IHE · iShares Trust | 0.20% | 541,635 SH | 2026년 8월 8일 | 일간 |
| IWC · iShares Trust | 0.19% | 463,783 SH | 2026년 8월 8일 | 일간 |
| IBB · iShares Trust | 0.07% | 1,158,886 SH | 2026년 8월 8일 | 일간 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.05% | 111,824 SH | 2026년 8월 8일 | 일간 |
| IWN · iShares Trust | 0.05% | 1,196,960 SH | 2026년 8월 8일 | 일간 |
| RSSL · Global X Funds | 0.03% | 60,562 NS | 2026년 4월 30일 | N-PORT |
| IWM · iShares Trust | 0.03% | 3,525,539 SH | 2026년 8월 8일 | 일간 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.02% | 793,588 SH | 2026년 8월 8일 | 일간 |
| ISCV · iShares Trust | 0.02% | 18,901 SH | 2026년 8월 8일 | 일간 |
| ISCB · iShares Trust | 0.01% | 6,085 SH | 2026년 8월 8일 | 일간 |
| DFAS · Dimensional ETF Trust | 0.01% | 250,409 NS | 2026년 4월 30일 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 1,751,403 SH | 2026년 8월 8일 | 일간 |
| VHT · VANGUARD WORLD FUND | 0.01% | 390,910 SH | 2026년 8월 8일 | 일간 |
| ISCG · iShares Trust | 0.01% | 14,793 SH | 2026년 8월 8일 | 일간 |
| WSML · iShares Trust | 0.01% | 7,226 SH | 2026년 8월 8일 | 일간 |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.00% | 4,467 NS | 2026년 5월 31일 | N-PORT |
| IWO · iShares Trust | 0.00% | 86,005 SH | 2026년 8월 8일 | 일간 |
| DFAU · Dimensional ETF Trust | 0.00% | 43,085 NS | 2026년 4월 30일 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.00% | 1,463 NS | 2026년 4월 30일 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 10,250 NS | 2026년 4월 30일 | N-PORT |
| IWV · iShares Trust | 0.00% | 63,707 SH | 2026년 8월 8일 | 일간 |
| ITOT · iShares Trust | 0.00% | 248,385 SH | 2026년 8월 8일 | 일간 |
| DFAC · Dimensional ETF Trust | 0.00% | 74,011 NS | 2026년 4월 30일 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 18,648 NS | 2026년 4월 30일 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.00% | 10,069 SH | 2026년 8월 8일 | 일간 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 11,431 SH | 2026년 8월 8일 | 일간 |